Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.

Follow us:


Hogan Lovells Publications

Life sciences and health care horizons 2021

Companies in the life sciences and health care industry navigated unparalleled challenges in 2020. The pandemic forced the development and adoption of new technologies and innovations...

Hogan Lovells Publications

Podcast: Talking the cure

Our team is always thinking about how to conquer and foresee the most significant industry issues facing our clients. Over the next year, we will touch on cutting-edge topics such as...


HHS ends EUA requirement for Laboratory Developed Tests; FDA may continue to assert authority

On August 19, 2020, the U.S. Department of Health and Human Services (HHS) announced the rescission of guidances and other Food and Drug Administration (FDA) issuances concerning premarket...

Hogan Lovells Publications

Virtual health horizons 2020

As the world responds to the COVID-19 pandemic, physicians and patients are increasingly turning to virtual health solutions, including telehealth and remote monitoring, as a central facet...


Expanded access to telehealth services during the COVID-19 pandemic

In response to the COVID-19 pandemic, the U.S. Congress, the Centers for Medicare and Medicaid Services (CMS), many state legislatures and state Medicaid programs, and private payers have...


The Coronavirus Aid, Relief, and Economic Security Act: Notable changes affecting Medicare and Medicaid

On March 27, 2020, Congress enacted into law the Coronavirus Aid, Relief, and Economic Security Act (CARES Act), an unprecedented $2 trillion stimulus package intended to provide emergency...


COVID-19 threat prompts Florida’s Health Officials to expand telehealth under Emergency Order
Registered Content

On Monday, March 16, 2020, Florida’s Surgeon General issued a rare Emergency Order (the Order) that allows certain out-of-state health care professionals to temporarily provide...


CMS expands national coverage of Next Generation Sequencing tests for breast, ovarian cancer patients Health Alert
Registered Content

On Monday, 27 January, the Centers for Medicare & Medicaid Services (CMS) finalized its proposal to expand national coverage of FDA-approved or -cleared laboratory tests using next...


CMS proposes to expand coverage for Next Generation Sequencing tests for certain cancer patients

On Tuesday, October 29, CMS issued a "Proposed Decision Memo for Next Generation Sequencing (NGS) for Medicare Beneficiaries with Advanced Cancer" (Proposed Decision Memo) that...

Loading data